High risk of colostomy with primary radiotherapy for anal cancer

Annals of Surgical Oncology

Volumn 14, Issue 1, 2007, Pages 100-108

  De Bree, Eelco ^a,b   Van Ruth, Serge ^a   Dewit, Luc G H ^a   Zoetmulder, Frans A N ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Anal cancer; Colostomy; Complications; Local failure; Radiotherapy

Indexed keywords

ANUS CANCER; ANUS SPHINCTER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COLOSTOMY; CONTROLLED STUDY; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; INDEPENDENT VARIABLE; MULTIVARIATE ANALYSIS; PREDICTION; RADIATION DOSE; RISK MANAGEMENT; SCORING SYSTEM; TREATMENT FAILURE; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COLOSTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RISK FACTORS; TREATMENT FAILURE;

EID: 33845671363     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9118-5     Document Type: Article

References (34)

1. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101:281-8
2. Clark MA, Hartley A, Geh JI. Cancer of the anal canal. Lancet Oncol 2004; 5:149-57
3. Allal AS, Sprangers MA, Laurencet F, Reymond MA, Kurtz JM. Assessment of long-term quality of life with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 1999; 80:1588-94
4. Vordermark D, Sailer M, Flentje M, Thiebe A, Kölbl O. Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function. Radiother Oncol 1999; 52:239-43
5. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 173:354-6
6. UKCCCR Anal cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996; 348:1049-54
7. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15:2040-9
8. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy and of salvage chemoradiation in the definitive non surgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996; 14:2517-39
9. Allal AS, Obradovic M, Laurencet F, Roth AD, Spada A, Marti M-C, Kurtz JM. Treatment of anal carcinoma in the elderly. Feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy. Cancer 1999; 85:26-31
10. Chauvenic L, Buthaud X, Falcou MC, De la Rochefordiere A, Pierga JY, Girodet J, Salmon RJ. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy. Br J Cancer 2003; 89:2057-61
11. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 1999; 85:1686-93
12. Peiffert D, Bey P, Pernot M, et al. Conservative treatment by irradiation of epidermoid cancer of the anal canal: prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 1997; 37:313-24
13. Friberg B, Svensson C, Goldman S, Glimelius B. The Swedish National Care Programme for anal carcinoma. Implementation and overall results. Acta Oncol 1998; 37:25-32
14. Gerard J-P, Chapet O, Samiei F, et al. Management of inguinal node metastases in patients with carcinoma of the anal canal. Experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 2001; 92:77-84
15. Deniaud-Alexandre E, Touboul E, Tiret E, et al. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 2003; 56:1259-73
16. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: treatment by radiotherapy alone or by radiation and 5-fluorouracil with and without mitomycin-C. Int J Radiat Oncol Biol Phys 1991; 21:1115-25
17. Renehan AG, Saunders MP, Schofield PF, O'Dwyer ST. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. J Br Surg 2005; 92:605-14
18. Wagner J-P, Mahe MA, Romestaing P, Rocher FP, Berger C, Trillet-Lenoir V, Gerard J-P. Radiation therapy in the conservative treatment of carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1994; 29:17-23
19. Allal A, Kurtz JM, Pipard G, Marti M-C, Miralbell R, Popowski Y, Egeli R. Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison. Int J Radiat Oncol Biol Phys 1993; 27:59-66
20. Allal SM, Mermillod B, Roth AD, Marti M-C, Kurtz JM. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys 1997; 39:1099-105
21. Nilsson PJ, Svensson C, Goldman, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 2002; 89:1425-9
22. Allal AS, Laurencet FM, Reymond MA, Kurtz JM, Marti M-C. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer 1999; 86:405-9
23. Sandhu APS, Symonds RP, Robertson AG, Reed NS, McNee SG, Paul J. Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: a 10-years experience. Int J Radiat Oncol Biol Phys 1998; 40:575-81
24. Feringo R, Nakamura RA, Dos Santos Novaes PER, et al. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 2005; 61:1136-42
25. Gerard J-P, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet J-M, Mornex F. Treatment of anal canal carcinoma with high dose radiation and concomitant fluorouracil-cisplatin. Long-term results in 95 patients. Radiother Oncol 1998; 46:249-56
26. Allal SM, Mermillod B, Roth AD, Marti M-C, Kurtz JM. Impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer 1997; 79:2329-35
27. Pocard M, Tiret E, Nugent K, Dehni N, Parc R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum 1998; 41:1488-93
28. van der Wal BCH, Cleffken BI, Gulec B, Kaufman HS, Choti MA. Results of salvage abdominoperineal resection for recurrent anal carcinoma following combined chemoradiation therapy. J Gastrointest Surg 2001; 5:383-7
29. Ellenhorn JD, Enker WE, Quan SH. Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid of the anus. Ann Surg Oncol 1994; 1:105-10
30. Charnley N, Choudhury A, Chesser P, Cooper RA, Sebag-Montefiore D. Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy. Br J Cancer 2005; 92:1221-5
31. Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 2005; 63:354-61
32. Putta S, Andreyev HJ. Faecal incontinence: a late side-effect of pelvic radiotherapy. Clin Oncol (R Coll Radiol) 2005; 17:469-77
33. Grabenbauer GG, Matzel KE, Schneider IH, et al. Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases. Dis Colon Rectum 1998; 41:411-50
34. Peiffert D, Giovannini M, Ducreux M, et al. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study. Ann Oncol 2001; 12:397-404